Pharmaceutical dosage form for transdermal administration
US6538039B2 · kind B2 · utility
79Cited by
4References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 31, 1996 |
| Grant date | Mar 25, 2003 |
| Priority date | — |
| Expiry date | Oct 31, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7015
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a process for administering an active principle to a patient transdermally, which comprises the formation of a film on the patient's skin, by applying to the skin a liquid solution which consists essentially of:a) a lipophilic active principle,b) from 2.5 to 25% by weight of a silicone-based adhesive polymer composition,c) from 0 to 25% by weight of an absorption promoter, andd) from 25 to 95% by weight of volatile solvents comprising volatile silicones.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.